Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetic patients.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Circulation Journal

• Publication date

  2007-06-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1253/CIRCJ.71.1067PMID 17587712
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of abnormal glucose tolerance, hypertension and other risk factors on coronary artery disease.

  2007cited by this paper
• Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications.

  2006cited by this paper
• C-reactive protein (CRP)-lowering agents.

  2006cited by this paper
• Advanced glycation end products in renal failure.

  2006cited by this paper
• Association of Hemoglobin A1c Level With the Severity of Coronary Artery Disease in Patients With Diabetes Mellitus

  2006cited by this paper
• [The role of C-reactive protein and other acute phase markers in atherosclerosis].

  2006cited by this paper
• Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals.

  2006cited by this paper
• [Oxidative stress and protein glycation in diabetes mellitus].

  2006cited by this paper
• Impact of abnormal glucose tolerance, hypertension and other risk factors on coronary artery disease

  2006cited by this paper
• Fasting triglyceride is a significant risk factor for coronary artery disease in middle-aged Japanese men.

  2006cited by this paper
• Association of hemoglobin A(1c) level with the severity of coronary artery disease in patients with diabetes mellitus.

  2006cited by this paper
• Stress oxydant et glycation des protéines au cours du diabète sucré

  2006cited by this paper
• [The role of C-reactive protein and other acute phase markers in atherosclerosis].

  2006cited by this paper
• Low-grade inflammation, thrombogenicity, and atherogenic lipid profile in cigarette smokers.

  2006cited by this paper
• Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.

  2005cited by this paper
• Chronic Renal Dysfunction as an Independent Risk Factor for the Development of Cardiovascular Disease

  2005cited by this paper
• Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation.

  2005cited by this paper
• Peroxisome Proliferator-Activated Receptor-Alpha and Atherosclerosis: From Basic Mechanisms to Clinical Implications

  2005cited by this paper
• Improvement of Function and Morphology of Tumor Necrosis Factor-α Treated Endothelial Cells With 17-β Estradiol

  2005cited by this paper
• Improvement of function and morphology of tumor necrosis factor-alpha treated endothelial cells with 17-beta estradiol: a preliminary study for a feasible simple model for atherosclerosis.

  2005cited by this paper
• Endothelial function, CRP and oxidative stress in chronic kidney disease.

  2005cited by this paper
• Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

  2004cited by this paper
• Protein Glycation: A Firm Link to Endothelial Cell Dysfunction

  2004cited by this paper
• Time course of specific AGEs during optimised glycaemic control in type 2 diabetes.

  2004cited by this paper
• Amadori-configurated albumin induces nitric oxide-dependent apoptosis of endothelial cells: a possible mechanism of diabetic vasculopathy.

  2004cited by this paper
• Glycation, Inflammation, and RAGE: A Scaffold for the Macrovascular Complications of Diabetes and Beyond

  2003cited by this paper
• Impact of diabetes mellitus on angiographically silent coronary atherosclerosis.

  2003cited by this paper
• Impact of Diabetes Mellitus on Angiographically Silent Coronary Atherosclerosis An Intravascular Ultrasound Study

  2003cited by this paper
• Intervention strategies to prevent pathogenetic effects of glycated albumin.

  2003cited by this paper
• Advanced glycation in uraemic toxicity.

  2003cited by this paper
• High oxidative stress in patients with stable coronary heart disease.

  2003cited by this paper
• Advanced glycation in uraemic toxicity.

  2003cited by this paper
• Vascular Smooth Muscle Cell Activation by Glycated Albumin (Amadori Adducts)

  2002cited by this paper
• Glycated serum albumin-induced nitric oxide production in vascular smooth muscle cells by nuclear factor kappaB-dependent transcriptional activation of inducible nitric oxide synthase.

  1999cited by this paper
• The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation.

  1999cited by this paper
• ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions.

  1999cited by this paper
• A comparison of quantitative computerized and human panel coronary endpoint measures: implications for the design of angiographic trials.

  1997cited by this paper

• Assessment of Glycated Albumin in Patient with Acute Coronary Syndromes and Its Correlation with Short Term Outcomes

  2025cites this paper
• Mediation effect of body mass index on the association between glycated albumin and 10-year atherosclerotic cardiovascular disease risk in Hunan residents of China: a retrospective cross-sectional study

  2025cites this paper
• Level of IL-6, TNF, and IL-1β and age-related diseases: a systematic review and meta-analysis

  2024cites this paper
• Prognostic value of serum glycated albumin in acute coronary syndrome patients without standard modifiable cardiovascular risk factors

  2024cites this paper
• Correlation between glycated albumin (GA) and CHA2DS2-VASc score in comparison to GRACE score regarding outcomes in acute coronary syndrome patients undergoing percutaneous coronary intervention

  2024cites this paper
• Serum levels of lipoprotein-associated phospholipase A2 are associated with coronary atherosclerotic plaque progression in diabetic and non-diabetic patients

  2024cites this paper
• Detection of Biomarker Using Aptasensors to Determine the Type of Diabetes

  2023cites this paper
• Relationship between red blood cell-related indices and coronary artery calcification.

  2023cites this paper
• Correlation between Glycated Hemoglobin (HBA1c), Glycated Albumin Levels and Cardiovascular Risk Factors in Pre-Diabetic Metabolic Syndrome Patients..

  2023cites this paper
• Association between the inflammatory biomarker YKL-40 (chitinase-3-like 1) in type-2 diabetic patients and ischemic heart diseases

  2022cites this paper
• Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus

  2022cites this paper
• Serum MPO levels and activities are associated with angiographic coronary atherosclerotic plaque progression in type 2 diabetic patients

  2022cites this paper
• Serum glycated albumin is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents: An observational study

  2022cites this paper
• Glycated albumin as medium-term glycemic control in diabetes mellitus

  2021cites this paper
• Elevated Glycated Albumin in Serum Is Associated with Adverse Cardiac Outcomes in Patients with Acute Coronary Syndrome Who Underwent Revascularization Therapy

  2021cites this paper
• Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention

  2021cites this paper
• Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus.

  2021cites this paper
• Investigating the relationship between myocardial infarction and the ratio of glycated albumin to glycated hemoglobin in patients admitted to cardiac ward

  2020cites this paper
• Association of Hemoglobin A1c, 1,5-Anhydro-d-Glucitol and Glycated Albumin with Oxidative Stress in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study

  2020cites this paper
• Correlations Between Glycemic Parameters Obtained from Continuous Glucose Monitoring and Hemoglobin A1c and Glycoalbumin Levels in Type 2 Diabetes Mellitus.

  2020cites this paper
• Recent Updates and Advances in the Use of Glycated Albumin for the Diagnosis and Monitoring of Diabetes and Renal, Cerebro- and Cardio-Metabolic Diseases

  2020cites this paper
• Association between serum glycated albumin and risk of cardiovascular disease in a Japanese community: The Hisayama Study.

  2020cites this paper
• The Modern Western Diet Rich in Advanced Glycation End-Products (AGEs): An Overview of Its Impact on Obesity and Early Progression of Renal Pathology

  2019cites this paper
• Serum protein signature of coronary artery disease in type 2 diabetes mellitus

  2019cites this paper
• The Role of Glycated Hemoglobin A1c in Determining the Severity of Coronary Artery Disease in Diabetic and Non-Diabetic Subjects in Karachi

  2019cites this paper
• Recently Uncontrolled Glycemia in Diabetic Patients Is Associated with the Severity of Intracranial Atherosclerosis.

  2017cites this paper
• Association of glycated albumin to HbA1c ratio with diabetic retinopathy but not diabetic nephropathy in patients with type 2 diabetes.

  2017cites this paper
• Glycated albumin (GA) and inflammation: role of GA as a potential marker of inflammation

  2017cites this paper
• Glycated albumin and its variability as an indicator of cardiovascular autonomic neuropathy development in type 2 diabetic patients

  2017influential citation
• Glycated Albumin Versus HbA1c in the Evaluation of Glycemic Control in Patients With Diabetes and CKD

  2017cites this paper
• Levels of Glycated Albumin and C-Reactive Protein as Risk Markers of Coronary Artery Disease in Type-2 Diabetics

  2016cites this paper
• Associations of glycated haemoglobin A1c and glycated albumin with subclinical atherosclerosis in middle‐aged and elderly Chinese population with impaired glucose regulation

  2015cites this paper
• Advantages and Pitfalls of Fructosamine and Glycated Albumin in the Diagnosis and Treatment of Diabetes

  2015cites this paper
• Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama Study

  2015cites this paper
• Glycated albumin and glycated hemoglobin levels as a measure of control in diabetic patients attending out-patient clinic at Kenyatta National Hospital: a comparative study

  2015cites this paper
• Associations between glycated albumin or hemoglobin A1c and the presence of coronary artery disease.

  2015cites this paper
• Oxidized LDL and Fructosamine Associated with Severity of Coronary Artery Atherosclerosis in Insulin Resistant Pigs Fed a High Fat/High NaCl Diet

  2015cites this paper
• Relations between Preoperative Glycated Albumin Levels and Co-Morbidity in Patients Undergoing Surgery

  2015cites this paper
• Glycated albumin as a diagnostic tool for diabetes in a general Japanese population.

  2015cites this paper
• Glycated proteins: Clinical utility and analytical approaches

  2015cites this paper
• Utility of different glycemic control metrics for optimizing management of diabetes.

  2015cites this paper
• Glycated albumin; clinical usefulness.

  2014cites this paper
• "Glycated Albumin" A New Paradigm In Better Monitoring Type 2 Diabetes Complications As A Short Term Glycemic Index.

  2014influential citation
• 1,5-Anhydroglucitol and glycated albumin in glycemia.

  2014cites this paper
• A newer conversion equation for the correlation between HbA1c and glycated albumin.

  2014cites this paper
• Calorimetric investigation of diclofenac drug binding to a panel of moderately glycated serum albumins.

  2014influential citation
• Immune response to chemically modified proteome

  2014cites this paper
• Glycated Albumin – More Than the Missing Link in the Evaluation of Diabetes Control

  2014cites this paper
• Glycated albumin and diabetes mellitus.

  2013cites this paper
• Association of glycated albumin with the presence of carotid plaque in patients with type 2 diabetes

  2013cites this paper
• Clinical, pathophysiological and structure/function consequences of modification of albumin by Amadori-glucose adducts.

  2013cites this paper
• Glycated Albumin, Rather than Hba1c, Reflects Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus

  2013cites this paper
• Advanced glycated albumin isolated from poorly controlled type 1 diabetes mellitus patients alters macrophage gene expression impairing ABCA‐1‐mediated reverse cholesterol transport

  2013cites this paper
• Evaluation of biological variation of glycated albumin (GA) and fructosamine in healthy subjects.

  2013cites this paper
• Raman spectroscopy-based sensitive and specific detection of glycated hemoglobin.

  2012cites this paper
• Glycated albumin in diabetic patients with chronic kidney disease.

  2012cites this paper
• Review of the Potential Glycemic Markers Glycated Albumin and 1,5-anhydroglucitol

  2012cites this paper
• Value of Serum Glycated Albumin in Prediction of Coronary Artery Disease in Type 2 Diabetes Mellitus

  2012cites this paper
• Serum advanced glycation end-products and receptors as prognostic biomarkers in diabetics undergoing coronary artery stent implantation.

  2012cites this paper
• Two Reflections about Amadori Products: Biomarkers or Therapeutic Targets for Coronary Artery Disease?

  2012cites this paper
• Adipokines and Vascular Risk in Type 2 Diabetes Mellitus

  2011influential citation
• Effects of atorvastatin on progression of diabetic nephropathy and local RAGE and soluble RAGE expressions in rats

  2011cites this paper
• Retinal Microglial Activation and Inflammation Induced by Amadori-Glycated Albumin in a Rat Model of Diabetes

  2011cites this paper
• The quest for the perfect biomarker of long-term glycemia: new studies, new trials and tribulations.

  2011cites this paper
• Glycated albumin is the preferred marker for assessing glycaemic control in advanced chronic kidney disease

  2011cites this paper
• Receptor Mediated Elevation in FABP4 Levels by Advanced Glycation End Products Induces Cholesterol and Triacylglycerol Accumulation in THP-1 Macrophages

  2011cites this paper
• Glycated albumin is independently associated with estimated glomerular filtration rate in nondiabetic patients with chronic kidney disease.

  2011cites this paper
• Diabetes Research and Clinical Practice

  2010cites this paper
• Evaluation of error levels in hemoglobin A1c and glycated albumin in type 2 diabetic patients due to inter-individual variability.

  2010cites this paper
• Glycated albumin levels are higher relative to glycated haemoglobin levels in gastrectomized subjects

  2010cites this paper
• Identification and Assessment of Plasma Lysozyme as a Putative Biomarker of Atherosclerosis

  2010cites this paper
• Clinical impact of glycated albumin as another glycemic control marker.

  2010cites this paper
• Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM).

  2010cites this paper
• Influence of insulin resistance on long-term outcomes in patients.

  2010cites this paper
• Diabetes and vascular disease: basic concepts of nitric oxide physiology, endothelial dysfunction, oxidative stress and therapeutic possibilities.

  2010cites this paper
• Analysis of the method for conversion between levels of HbA1c and glycated albumin by linear regression analysis using a measurement error model.

  2009cites this paper
• Endogenous insulin secretion and glycated proteins Glycated albumin and glycated hemoglobin are differently influenced by endogenous insulin secretion in patients with type 2 diabetes mellitus

  2009cites this paper
• Vessel Shrinkage as a Sign of Atherosclerosis Progression in Type 2 Diabetes

  2009cites this paper
• Association of serum glycated albumin, C-reactive protein and ICAM-1 levels with diffuse coronary artery disease in patients with type 2 diabetes mellitus.

  2009cites this paper
• Glycated Albumin and Glycated Hemoglobin Are Influenced Differently by Endogenous Insulin Secretion in Patients With Type 2 Diabetes

  2009cites this paper
• Predictive value of the decrease in circulating dendritic cell precursors in stable coronary artery disease.

  2009cites this paper
• A Review of Glycated Albumin as an Intermediate Glycation Index for Controlling Diabetes

  2008cites this paper
• cursors in stable coronary artery disease

  2008cites this paper
• Glycation as an atherogenic modification of LDL

  2008cites this paper
• Increased glycated albumin and decreased esRAGE concentrations are associated with in-stent restenosis in Chinese diabetic patients.

  2008cites this paper
• Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis.

  2008cites this paper
• Screening for coronary artery disease in asymptomatic patients with type 2 diabetes mellitus.

  2007cites this paper
• O R I G I N a L I N V E S T I G a T I O N Open Access

  year unknowncites this paper
• Prognostic value of serum glycated albumin in acute coronary syndrome patients without standard modi�able cardiovascular risk factors

  year unknowncites this paper